Preparation, Characterization, and Wound Healing Assessment of Curcumin-Loaded M-MOF (M = Cu, Zn)@Polycaprolactone Nanocomposite Sponges.

The fabrication of multifunctional scaffolds has attracted much attention in biological fields. In this research, some novel composites of Cu(II) or Zn(II) metal-organic framework (M-MOF) and polycaprolactone (PCL), M-MOF@PCL, have been fabricated as multifunctional scaffolds for application in the tissue engineering (TE) field. The porous three-dimensional sponges were prepared by the salt leaching method. Then, the M-MOF@PCL composite sponges have been prepared by in situ synthesis of M-MOF in the presence of the as-obtained PCL sponge to gain a new compound with proper features for biological applications. Finally, curcumin was attached to the M-MOF@PCL as a bioactive compound that can act as a wound-healing agent, anti-oxidant, and anti-inflammatory. The presence of the M-MOF in final composites was investigated by different methods such as FTIR (Fourier-transform infrared), XRD (X-ray diffraction), SEM (scanning electron microscope), EDS (energy-dispersive X-ray spectroscopy), and TEM (transmission electron microscope). SEM images confirmed the porous structure of the as-obtained composites. According to the EDS and TEM images, M-MOFs were uniformly incorporated throughout the PCL sponges. The water sorption capacities of the blank PCL, Cu-MOF@PCL, and Zn-MOF@PCL were determined as 56%, 155%, and 119%, respectively. In vivo investigation on a third-degree burn model in adult male Wistar rats exhibited an accelerated wound healing for Cu-MOF@PCL compared to with Zn-MOF@PCL and the control group.

New Hg(II) coordination polymers based on a thioimidazole ligand with good performance to detoxify Hg(II) and reversibly capture iodine.

In the current paper, we have successfully synthesized three new mercury coordination polymers with fascinating structures and properties via a flexible sulfur donor ligand, namely, {[Hg(µ2-Cl)(µ2-Ls)]}n[BF4]n(1), {[Hg(µ2-Cl)(µ2-Ls)]}n[ClO4]n(2), and [Hg(SCN)2(µ2-Ls)]n(3) [Ls = 1,1-bis(3-methyl-4-imidazoline-2-thione)methane]. These complexes have been characterized by means of different techniques such as single crystal X-ray crystallography, FT-IR, elemental analysis (CHNS), UV-Vis, PXRD, BET, and TGA. Suitable single crystals of all complexes were obtained using the branch tube method with a very high yield and good stability due to the high affinity of mercury to bind to the thione groups. The cationic moieties of polymers 1 and 2 were isostructural, with a HgCl2S2 coordination core structure. The voids of the quasi-hexagonal packing of the columnar chains were occupied by unbonded tetrahedral BF4- ions in 1 and perchlorate anions in polymer 2. Polymer 3 has a less distorted tetrahedral geometry than 1 and 2, with a HgS4 core structure. By considering the thiophilicity of mercury, a thioamide-based Ls ligand was used to detoxify Hg(II) into insoluble polymers 1-3. The results of an MTT assay for (HepG2) liver cells confirmed the excellent cytoprotective effect of this ligand against mercury. Based on IC50 calculations, their toxicity was in order of polymer 1 > polymer 2 > polymer 3. These polymers were also considered as adsorbents for the reversible removal of iodine from solution and the kinetics of the process has been studied in detail. Interestingly, all of them showed an excellent stability and high capacity, in order of 763.53 mg g-1, 877.10 mg g-1, and 905.31 mg g-1 for polymers 1-3, respectively.

Synthesis, characterization and biocompatibility of polypyrrole/Cu(II) metal-organic framework nanocomposites.

The main objective of composite science is to fabricate new materials with desired properties such as high chemical, mechanical, and/or biological performances. In this research, new conductive nanocomposites of copper metal-organic frameworks (Cu-MOF) and polypyrrole (PPy) were fabricated with the aim of exploiting the electrical conductivity of polypyrrole and the porosity of MOFs in the final products. The prepared compounds (PPy/x%Cu-MOF, x = 20, 50, and 80) were investigated by FTIR, PXRD, SEM, TEM, DLS, BET, EDS mapping, cyclic voltammetry (CV), and zeta potential (ξ) measurements. Spherical morphology was confirmed by SEM and TEM analysis. The PPy/80%Cu-MOF nanocomposite showed the highest ξ potential (-40 mV), demonstrating the stability of dispersed particles. The CV results revealed that the nanocomposites have higher capacitance in comparison to the pure materials. In vitro degradation of the as-prepared compounds in simulated body fluid (SBF) was studied by EIS (electrochemical impedance spectroscopy) and Tafel polarization tests. Furthermore, in vitro biocompatibility of the PPy/x%Cu-MOF composite was evaluated on a group of cells including 3T3 fibroblasts, MCF-7 breast cancer cells, J774.A1 macrophages and red blood cells (RBCs). Viability of 3T3 fibroblasts, MCF-7, and J774.A1 cells, by Methylthiazolyldiphenyl-tetrazolium bromide (MTT) method, was dependent on Cu-MOF percent and amount of composites. Hemolytic assay for RBCs exposed to different amounts of the PPy/x%Cu-MOF composites showed hematological toxicity less than 5% in most concentrations. In addition, to investigate pro-inflammatory activity, J774.A1 macrophages were exposed to non-toxic concentrations of the PPy/x%Cu-MOF and no significant change in the expression of two inflammatory genes COX-2 and iNOS was observed. Injection of the PPy/x%Cu-MOF (5 mg kg-1) into bloodstream of mice did not increase liver damage marker enzymes alanine transaminase (ALT) and aspartate transaminase (AST) level in serum 1 week post injection. Moreover, we observed slight but not significant increase in serum copper level in mice 1 week after injection. According to the results, the PPy/x%Cu-MOF nanocomposites exhibited a good in vitro and in vivo biocompatibility without inducing pro-inflammatory responses in macrophages and show promising potential for different biomedical applications such as biosensors and drug delivery. The release of curcumin from curcumin-loaded PPy/x%Cu-MOF nanocomposites was detectable in plasma of mice 4 days after administration.